Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)–based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with a VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogen...
Main Authors: | Andrea Marzi, Friederike Feldmann, Thomas W. Geisbert, Heinz Feldmann, David Safronetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2015-02-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/21/2/14-1649_article |
Similar Items
-
Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
by: Guodong Liu, et al.
Published: (2021-08-01) -
Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
by: Emmie de Wit, et al.
Published: (2015-04-01) -
Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
by: Katherine E. Havranek, et al.
Published: (2021-12-01) -
Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
by: Bharti Bhatia, et al.
Published: (2021-06-01) -
A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
by: Wenjun Zhu, et al.
Published: (2022-06-01)